Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.

Seeliger H, Pozios I, Assmann G, Zhao Y, Müller MH, Knösel T, Kreis ME, Bruns CJ.

BMC Cancer. 2018 Oct 29;18(1):1049. doi: 10.1186/s12885-018-4973-6.

2.

Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.

Pozios I, Knösel T, Zhao Y, Assmann G, Pozios I, Müller MH, Bruns CJ, Kreis ME, Seeliger H.

J Cancer Res Clin Oncol. 2018 Oct;144(10):1887-1897. doi: 10.1007/s00432-018-2717-2. Epub 2018 Jul 25.

PMID:
30046904
3.

Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.

Lu DY, Pozios I, Haileselassie B, Ventoulis I, Liu H, Sorensen LL, Canepa M, Phillip S, Abraham MR, Abraham TP.

J Am Heart Assoc. 2018 Feb 25;7(5). pii: e006657. doi: 10.1161/JAHA.117.006657.

4.

Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication.

Pozios I, Pinheiro A, Corona-Villalobos C, Sorensen LL, Dardari Z, Liu HY, Cresswell K, Phillip S, Bluemke DA, Zimmerman SL, Abraham MR, Abraham TP.

J Am Soc Echocardiogr. 2018 May;31(5):578-586. doi: 10.1016/j.echo.2017.11.002. Epub 2018 Feb 14.

PMID:
29426649
5.

E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction.

Lu DY, Haileselassie B, Ventoulis I, Liu HY, Liang HY, Pozios I, Canepa M, Phillip S, Abraham MR, Abraham T.

Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):101-107. doi: 10.1093/ehjci/jex134. Erratum in: Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):121.

PMID:
28977350
6.

Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.

Lu DY, Hailesealassie B, Ventoulis I, Liu H, Liang HY, Nowbar A, Pozios I, Canepa M, Cresswell K, Luo HC, Abraham MR, Abraham TP.

Int J Cardiol. 2017 Sep 15;243:290-295. doi: 10.1016/j.ijcard.2017.04.039.

PMID:
28747034
7.

Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy.

Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S, Lu DY, Ventoulis I, Luo H, Abraham MR, Abraham TP.

Am J Cardiol. 2017 Aug 15;120(4):670-675. doi: 10.1016/j.amjcard.2017.05.039. Epub 2017 May 30.

PMID:
28687124
8.

Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.

Hurtado-de-Mendoza D, Corona-Villalobos CP, Pozios I, Gonzales J, Soleimanifard Y, Sivalokanathan S, Montoya-Cerrillo D, Vakrou S, Kamel I, Mormontoy-Laurel W, Dolores-Cerna K, Suarez J, Perez-Melo S, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR.

J Arrhythm. 2017 Jun;33(3):201-207. doi: 10.1016/j.joa.2016.10.005. Epub 2016 Nov 19.

9.

Myocardial oxidative stress correlates with left ventricular dysfunction on strain echocardiography in a rodent model of sepsis.

Haileselassie B, Su E, Pozios I, Niño DF, Liu H, Lu DY, Ventoulis I, Fulton WB, Sodhi CP, Hackam D, O'Rourke B, Abraham T.

Intensive Care Med Exp. 2017 Dec;5(1):21. doi: 10.1186/s40635-017-0134-5. Epub 2017 Apr 12.

10.

Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients.

Corona-Villalobos CP, Saha S, Pozios I, Hurtado-de-Mendoza Paz D, Sorensen L, Gonzalez Cordoba J, Dolores-Cerna K, Kamel IR, Mormontoy Laurel W, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR.

J Electrocardiol. 2017 Jul - Aug;50(4):484-490. doi: 10.1016/j.jelectrocard.2017.02.002. Epub 2017 Feb 12. No abstract available.

PMID:
28292523
11.

Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.

Zhao Y, Altendorf-Hofmann A, Pozios I, Camaj P, Däberitz T, Wang X, Niess H, Seeliger H, Popp F, Betzler C, Settmacher U, Jauch KW, Bruns C, Knösel T.

J Cancer Res Clin Oncol. 2017 Jun;143(6):1061-1068. doi: 10.1007/s00432-017-2351-4. Epub 2017 Feb 17.

PMID:
28210844
12.

Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy.

Chu LC, Corona-Villalobos CP, Halushka MK, Zhang Y, Pozzessere C, Kamel IR, Pozios I, Van Der Geest RJ, Gai N, Abraham RM, Abraham TP, Bluemke DA, Zimmerman SL.

J Comput Assist Tomogr. 2017 Jul/Aug;41(4):653-660. doi: 10.1097/RCT.0000000000000564.

PMID:
27997439
13.

Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.

Sorensen LL, Liang HY, Pinheiro A, Hilser A, Dimaano V, Olsen NT, Hansen TF, Sogaard P, Nowbar A, Pisanello C, Pozios I, Phillip S, Zhou X, Abraham R, Abraham TP.

Am Heart J. 2017 Feb;184:47-54. doi: 10.1016/j.ahj.2016.10.010. Epub 2016 Oct 20.

14.

Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy.

Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, Kucukler N, Tahari A, Pozios I, Zhou Y, Pomper M, Abraham TP, Schindler TH, Abraham MR.

Am J Cardiol. 2016 Dec 15;118(12):1908-1915. doi: 10.1016/j.amjcard.2016.08.085. Epub 2016 Sep 15.

PMID:
27771003
15.

Nonobstructive Hypertrophic Cardiomyopathy: Low Mortality but Not Always Benign.

Pozios I, Abraham TP.

J Am Coll Cardiol. 2016 Aug 30;68(9):982-3. doi: 10.1016/j.jacc.2016.04.069. No abstract available.

16.

Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2.

Sørensen LL, Bedja D, Sysa-Shah P, Liu H, Maxwell A, Yi X, Pozios I, Olsen NT, Abraham TP, Abraham R, Gabrielson K.

Comp Med. 2016;66(4):268-77.

17.

Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Canepa M, Pozios I, Vianello PF, Ameri P, Brunelli C, Ferrucci L, Abraham TP.

Heart. 2016 Jul 15;102(14):1087-94. doi: 10.1136/heartjnl-2015-308764. Epub 2016 Apr 27. Review.

18.

Comparison of Clinical Features in Blacks Versus Whites With Hypertrophic Cardiomyopathy.

Sorensen LL, Pinheiro A, Dimaano VL, Pozios I, Nowbar A, Liu H, Luo HC, Lin X, Olsen NT, Hansen TF, Sogaard P, Abraham MR, Abraham TP.

Am J Cardiol. 2016 Jun 1;117(11):1815-20. doi: 10.1016/j.amjcard.2016.03.017. Epub 2016 Mar 19.

PMID:
27084053
19.

Strain Echocardiography Parameters Correlate With Disease Severity in Children and Infants With Sepsis.

Haileselassie B, Su E, Pozios I, Fiskum T, Thompson R, Abraham T.

Pediatr Crit Care Med. 2016 May;17(5):383-90. doi: 10.1097/PCC.0000000000000683.

20.

Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.

Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL.

Int J Cardiovasc Imaging. 2016 Jun;32(6):945-54. doi: 10.1007/s10554-016-0858-4. Epub 2016 Feb 19.

PMID:
26896038
21.

Pacemaker-induced transient asynchrony suppresses heart failure progression.

Kirk JA, Chakir K, Lee KH, Karst E, Holewinski RJ, Pironti G, Tunin RS, Pozios I, Abraham TP, de Tombe P, Rockman HA, Van Eyk JE, Craig R, Farazi TG, Kass DA.

Sci Transl Med. 2015 Dec 23;7(319):319ra207. doi: 10.1126/scitranslmed.aad2899.

22.

Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.

Pantsios C, Kapelios C, Vakrou S, Diakos N, Pozios I, Kontogiannis C, Nanas J, Malliaras K.

J Cardiovasc Pharmacol Ther. 2016 Jul;21(4):405-11. doi: 10.1177/1074248415617850. Epub 2015 Nov 20.

PMID:
26589289
23.

Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.

Pozios I, Corona-Villalobos C, Sorensen LL, Bravo PE, Canepa M, Pisanello C, Pinheiro A, Dimaano VL, Luo H, Dardari Z, Zhou X, Kamel I, Zimmerman SL, Bluemke DA, Abraham MR, Abraham TP.

Am J Cardiol. 2015 Sep 15;116(6):938-44. doi: 10.1016/j.amjcard.2015.06.018. Epub 2015 Jun 26.

24.

Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Bravo PE, Luo HC, Pozios I, Zimmerman SL, Corona-Villalobos CP, Sorensen L, Kamel IR, Bluemke DA, Wahl RL, Abraham MR, Abraham TP.

Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):293-300. doi: 10.1093/ehjci/jev154. Epub 2015 Jun 14.

25.

Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms.

Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP.

J Nucl Cardiol. 2016 Dec;23(6):1304-1314. Epub 2015 May 20.

PMID:
25989730
26.

Exercise heart rates in patients with hypertrophic cardiomyopathy.

Luo HC, Dimaano VL, Kembro JM, Hilser A, Hurtado-de-Mendoza D, Pozios I, Tomas MS, Yalcin H, Dolores-Cerna K, Mormontoy W, Aon MA, Cameron D, Bluemke DA, Stewart KJ, Russell SD, Cordova JG, Abraham TP, Abraham MR.

Am J Cardiol. 2015 Apr 15;115(8):1144-1150. doi: 10.1016/j.amjcard.2015.01.548. Epub 2015 Feb 4.

27.

Afterload-induced left ventricular diastolic dysfunction during myocardial ischaemia and reperfusion.

Diakos NA, Pozios I, Katsaros L, Vakrou S, Sventzouri S, Michelinakis N, Tseliou E, Bonios M, Malliaras K, Papalois A, Anastasiou-Nana M, Terrovitis JV.

Exp Physiol. 2015 Mar;100(3):288-301. doi: 10.1113/expphysiol.2014.082131. Epub 2015 Feb 2.

28.

Effects of intra-aortic balloon pump counterpulsation on left ventricular mechanoenergetics in a porcine model of acute ischemic heart failure.

Malliaras K, Charitos E, Diakos N, Pozios I, Papalois A, Terrovitis J, Nanas J.

J Cardiovasc Transl Res. 2014 Dec;7(9):810-20. doi: 10.1007/s12265-014-9600-6. Epub 2014 Nov 7.

PMID:
25376149
29.

Neuroticism personality trait is associated with Quality of Life in patients with Chronic Heart Failure.

Samartzis L, Dimopoulos S, Manetos C, Agapitou V, Tasoulis A, Tseliou E, Pozios I, Kaldara E, Terrovitis J, Nanas S.

World J Cardiol. 2014 Oct 26;6(10):1113-21. doi: 10.4330/wjc.v6.i10.1113.

30.

Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans.

Luo HC, Pozios I, Vakrou S, Sorensen L, Abraham RM, Abraham T.

J Huazhong Univ Sci Technolog Med Sci. 2014 Oct;34(5):634-639. doi: 10.1007/s11596-014-1329-6. Epub 2014 Oct 16.

PMID:
25318870
31.

Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.

Huang W, Liang J, Kazmierczak K, Muthu P, Duggal D, Farman GP, Sorensen L, Pozios I, Abraham TP, Moore JR, Borejdo J, Szczesna-Cordary D.

J Mol Cell Cardiol. 2014 Sep;74:318-29. doi: 10.1016/j.yjmcc.2014.06.011. Epub 2014 Jun 30.

32.

Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy.

Canepa M, Sorensen LL, Pozios I, Dimaano VL, Luo HC, Pinheiro AC, Strait JB, Brunelli C, Abraham MR, Ferrucci L, Abraham TP.

Am J Cardiol. 2013 Oct 15;112(8):1182-9. doi: 10.1016/j.amjcard.2013.05.070.

33.

Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.

Bravo PE, Zimmerman SL, Luo HC, Pozios I, Rajaram M, Pinheiro A, Steenbergen C, Kamel IR, Wahl RL, Bluemke DA, Bengel FM, Abraham MR, Abraham TP.

Circ Cardiovasc Imaging. 2013 Mar 1;6(2):210-7. doi: 10.1161/CIRCIMAGING.112.000110. Epub 2013 Feb 15.

34.

Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon.

Pierrakos CN, Tsolakis EJ, Pozios IA, Diakos N, Charitos E, Malliaras K, Bonios MJ, Lazaris N, Papazoglou P, Venetsanakos J, Papalois A, Terrovitis JV, Nanas JN.

Int J Cardiol. 2013 Sep 10;167(6):3000-5. doi: 10.1016/j.ijcard.2012.09.013. Epub 2012 Sep 27.

PMID:
23022088
35.

Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.

Bravo PE, Pozios I, Pinheiro A, Merrill J, Tsui BM, Wahl RL, Bengel FM, Abraham MR, Abraham TP.

Am J Cardiol. 2012 Oct 1;110(7):1033-9. doi: 10.1016/j.amjcard.2012.05.038. Epub 2012 Jun 28.

Supplemental Content

Loading ...
Support Center